Fig. 5: Prognostic value of cfRNAs in glioma. | npj Precision Oncology

Fig. 5: Prognostic value of cfRNAs in glioma.

From: Diagnostic and prognostic potential of cell-free RNAs in cerebrospinal fluid and plasma for brain tumors

Fig. 5

a, b Forest plot showing the hazard ratio (HR) (with 95% confidence interval) and log-rank p-value of CSF cfRNAs that were associated with poorer recurrence-free survival (RFS, a) and overall survival (OS, b). c Kaplan-Meier plot that shows the association of MAPK6 and tRF-18-07QSNHD2 with post-surgical RFS (red) and OS (orange). d Oncoprint showing the expression status and frequency of the prognostic cfRNAs in glioma patients. The vital status, recurrence status, and WHO grade of each patient are shown on the top. The HR for RFS and OS of each cfRNA are shown on the right. e Forest plot showing the HR (with 95% confidence interval) and log-rank p-value of genes that have prognostic values in both the glioma primary tumor tissue and CSF in the TCGA cohort.

Back to article page